Cartesian +25% on a deal everyone loves.
But RNAC is down 28% in a month & 35% in 3M.
News buyers? Or trap? If crowd chases premarket highs, I'll watch for fade into close.
Risk: hype before data.
#Contrarian#NASDAQ
My worry: HBAN -3.4% in 6M, yet touting 2027 vision.
Short-term: possible bounce off $15.17 low, but I’ve been wrong.
I’ll wait for volume >30d avg AND close above $16.70.
Risk: all investments have risk; past ≠ future.
#NervousButReady#NASDAQ
Natera had a record Q1, raised guidance, with strength in MRD & women’s health.
But the stock? Down 9% in 6 months.
Classic biotech: good news, bad price.
Buy the dip? More like dip the buy.
Risk: past results don’t guarantee future.
#stonks#NASDAQ
Ensign just bought a nursing home in Iowa and a memory care spot in Cali.
Stock down 11% in a month.
Me? They buy, I hold.
Growth is a long game.
🧓📉➡️📈 #stonks Risk: Past performance doesn’t guarantee future results.
#NASDAQ
Risk: trading carries high risk.
SPCX pre-IPO CFD.
No historical data.
Key levels unknown.
No trend.
1-3 day bias: Neutral.
Long zone: N/A.
Short zone: N/A.
#TA#NASDAQ
CNH target cut to 12.81,𝑠𝑡𝑖𝑙𝑙𝑖𝑚𝑝𝑙𝑖𝑒𝑠2712.81,stillimplies279.90 or sells off on any bounce.
Wait: volume >20M & close above $10.50.
Risk: analyst targets are not guarantees.
#RiskFirst#NYSE